Analysis of mortality from COVID-19 and obesity as a risk factor
DOI:
https://doi.org/10.33448/rsd-v11i1.23432Keywords:
Pandemic; COVID-19; SARS-CoV-2; Coronavirus; Comorbidity.Abstract
Obesity is caused by an increase in the mass of adipose tissue, being considered a multifactorial disease that can be avoided. The main triggering factor is energy imbalance, due to the high level of calories consumed and low energy activity. In Brazil, obesity grew by 67.8%, being one of the most significant factors in patients with COVID-19. COVID-19 (coronavirus disease 2019) is a respiratory infection caused by the SARS-CoV-2 coronavirus, which can progress from a flu to Severe Acute Respiratory Syndrome until death. The current pandemic has a recent onset and a rapid pace of development due to its high rate of transmission and global distribution. The body of scientific evidence is still sparse, each outbreak that arises is an opportunity to obtain more information about the virus. This work aims to contribute to increasing knowledge of the COVID-19 pandemic by evaluating the mortality rate from COVID-19 associated with obesity as a risk factor, observing the epidemiological bulletins from April 2020 to August 2021 of Coronavirus Disease 2019, with emphasis on deaths, according to age, sex and region of greatest prevalence. Thus, as a result of the collected data, it is observed that the Midwest region has the highest incidence, the male gender is more prevalent and obesity is the main risk factor for children under 60 years of age. Therefore, it is necessary for the country to intensify surveillance actions for aggravating factors, such as obesity, which is a modifiable risk factor.
References
ABESO - Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica. (2021). Mapa da obesidade. https://abeso.org.br/obesidade-e-sindrome-metabolica/mapa-da-obesidade/
Bolsoni-Lopes, A., Furieri, L. B. & Alonso-Vale, M. I. C. (2021). Obesidade e a covid-19: uma reflexão sobre a relação entre as pandemias. Revista Gaúcha de Enfermagem, 42.
Brasil - Ministério da Saúde. (2020a). Boletim epidemiológico especial, número 06, 3 de abril de 2020. Doença pelo Coronavírus COVID-19. https://portalarquivos.saude.gov.br/images/pdf/2020/April/03/BE6-Boletim-Especial-do-COE.pdf.
Brasil - Ministério da Saúde. (2020b). Secretaria de Vigilância em Saúde, Boletim Epidemiológico Volume 51, Nº 27 Jul. 2020. https://antigo.saude.gov.br/images/pdf/2020/July/09/Boletim-epidemiologico-SVS-27-06.07.2020.pdf.
Brasil - Ministério da Saúde. (2021a). Boletim epidemiológico especial, número 52. Doença pelo Coronavírus COVID-19. Semana Epidemiológica 8 (21 a 27/2/2021). https://www.gov.br/saude/pt-br/media/pdf/2021/marco/05/boletim_epidemiologico_covid_52_final2.pdf.
Brasil - Ministério da Saúde. (2021b). Boletim epidemiológico especial, número 28. Doença pelo Coronavírus COVID-19. Semana Epidemiológica 34 (16 a 22/08)). https://antigo.saude.gov.br/images/pdf/2020/August/27/Boletim-epidemiologico-COVID-28-FINAL-COE.pdf.
Cândido, J. A. B., Moreira, M. R. C., Alexandre, S. F., Parente, N. C., & Cavalcante, N. R. P. (2021). Obesidade em paciente com prognóstico de gravidade para Covid-19. Research, Society and Development, 10(10), e459101019121. https://doi.org/10.33448/rsd-v10i10.19121
Chait, A., & den Hartigh, L. J. (2020). Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease. Frontiers in cardiovascular medicine, 7, 22. https://doi.org/10.3389/fcvm.2020.00022
Domingues, C. M. A. S. (2021). Desafios para a realização da campanha de vacinação contra a COVID-19 no Brasil.
Ferreira, A. P. D. S., Szwarcwald, C. L. & Damacena, G. N. (2019). Prevalência de obesidade e fatores associados na população brasileira: um estudo com dados da Pesquisa Nacional de Saúde 2013. Revista Brasileira de Epidemiologia, 22.
Fonseca-Alaniz, M. H., Takada, J., Alonso-Vale, M. I. C. & Lima, F. B. (2006). O tecido adiposo como centro regulador do metabolismo. Arquivos Brasileiros de Endocrinologia & Metabologia, 50, 216-229.
Gregório, M. J., Santos, A., & Graça, P. (2021). Obesity and COVID-19: Present and Future. Acta Médica Portuguesa, 34(5), 329-331.
Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., ... & Zhong, N. S. (2020). Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine, 382(18), 1708-1720.
Halpern, B., Louzada, M. L. D. C., Aschner, P., Gerchman, F., Brajkovich, I., Faria‐Neto, J. R., ... & Franco, O. H. (2021). Obesidade e COVID-19 na América Latina: a tragédia de duas pandemias - Documento oficial da Federação Latino-Americana de Sociedades de Obesidade. Comentários sobre obesidade, 22 (3), e13165.
Lana, R. M., Coelho, F. C., Gomes, M. F. D. C., Cruz, O. G., Bastos, L. S., Villela, D. A. M., & Codeço, C. T. (2020). Emergência do novo coronavírus (SARS-CoV-2) e o papel de uma vigilância nacional em saúde oportuna e efetiva. Cadernos de Saúde Pública, 36, e00019620.
Malavazos, A. E., Romanelli, M. M. C., Bandera, F., & Iacobellis, G. (2020). Visando o tecido adiposo em COVID ‐ 19. Obesidade (Silver Spring, MD).
Malta, D. C., Szwarcwald, C. L., Barros, M. B. D. A., Gomes, C. S., Machado, Í. E., Souza, P. R. B. D., ... & Gracie, R. (2020). The COVID-19 Pandemic and changes in adult Brazilian lifestyles: a cross-sectional study, 2020. Epidemiologia e Serviços de Saúde, 29.
SIVEP-Gripe - Sistema de Informação de Vigilância da Gripe. (2021). https://sivepgripe.saude.gov.br/sivepgripe/
Souza, L. E. P. F. D. & Buss, P. M. (2021). Desafios globais para o acesso equitativo à vacinação contra a COVID-19. Cadernos de Saúde Pública, 37, e00056521.
VIGITEL - Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico. (2019). https://bvsms.saude.gov.br/bvs/publicacoes/vigitel_brasil_2019_vigilancia_fatores_risco.pdf
WHO - World Health Organization. (2020). Obesity and overweight. https://www.who.int/newsroom/fact-sheets/detail/obesity-and-overweight
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Luciana Dorneles Siqueira; Juan Domingos Muchon; Jalsi Tacon Arruda; Raquel Loren dos Reis Paludo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
